Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis

Kidney International

Volumn 56, Issue 2, 1999, Pages 571-580

  Ophascharoensuk, Vuddhidej ^a,b   Giachelli, Cecilia M ^a,b   Gordon, Katherine ^a,b   Hughes, Jeremy ^a,b   Pichler, Raimund ^a,b   Brown, Paul ^a,b   Liaw, Lucy ^a,b   Schmidt, Rodney ^a,b   Shankland, Stuart J ^a,b   Alpers, Charles E ^a,b   Couser, William G ^a,b   Johnson, Richard J ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Maine Medical Center Research Institute   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Cell apoptosis; Fibrosis; Macrophages; Tubulointerstitial injury; Unilateral ureteral obstruction

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY TUBULE CELL; MACROPHAGE; MOUSE; NONHUMAN; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; URETER LIGATION;

EID: 0032782749     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00580.x     Document Type: Article

References (45)

1. 1. RISDON RA, SLOPER DE, VARDENER JC: Relationship between renal function and histologic changes found in renal-biopsy specimens from patients with persistent glomerulonephritis. Lancet 2:363-366, 1968
2. 2. SCHAINUCK LI, STRIKER GE, CUTLER R, BENDITT EP: Structural-functional correlations in renal disease. Part II. The correlations. Hum Pathol 1:631-641, 1970
3. 3. BOHLE A, MÜLLER GA, WEHRMANN M, MACKENSEN-HAEN S, XIAO JC: Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int 49(Suppl):S2-S9, 1996
4. 4. FLOEGE J, ALPERS CE, BURNS MW, PRITZL P, GORDON K, COUSER WG, JOHNSON RJ: Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 66:485-497, 1992
5. 5. YOUNG BA, BURDMANM EA, JOHNSON RJ, ALPERS CE, GIACHELLI CM, ENG E, ANDOH T, BENNETI WM, COUSER WG: Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 48:439-448, 1995
6. 6. EDDY AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 5:1273-1287, 1994
7. 7. PICHLER R, GIACHELLI CM, YOUNG BA, ALPERS CE, COUSER WG, JOHNSON RJ: The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: The glomerular cytokine hypothesis. Miner Electrolyte Metab 21:317:327, 1995
8. 8. HILL PA, LAN HY, NICKOLIC-PATERSON DJ, ATKINS RC: ICAM-1 directs migration and localization of interstitial leukocytes in experimental glomerulonephritis. Kidney Im 45:32-42, 1994
9. 9. DENHARDT D, GUO X: Osteopontin: a protein with diverse functions. FASEB J 7:1475-1482, 1993
10. 10. GIACHELLI CM, SCHWARTZ SM, LIAW L: Molecular and cellular biology of osteopontin. Potential role in cardiovascular disease. Trends Cardiovas Med 5:88-95, 1995
11. 11. GIACHELLI CM, LOMBARDI D, JOHNSON RJ, MURRY CE, ALMEIDA M: Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353-358, 1998
12. 12. GIACHELLI CM, PICHLER R, LOMBARDI D, DENHARDI DT, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45:515-524, 1994
13. 13. PICHLER R, GIACHELLI CM, LOMBARDI D, PIPPIN J, GORDON K, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Am J Pathol 144:915-926, 1994
14. 14. EDDY AA, GIACHELLI CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47:1546-1557, 1995
15. 15. DIAMOND JR, KEES-FOLTS D, RICARDO SD, PRUZNAK A, EUFEMIO M: Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 146: 1455-1466, 1995
16. 16. KLAHR S: New insights into the consequence and mechanisms of renal impairment in obstructive uropathy. Am J Kidney Dis 18:689-699, 1991
17. 17. LIAW L, BIRK DE, BALLAS CB, WHITSITI JS, DAVIDSON JM, HOGAN BLM: Altered wound healing in mice lacking a functional osteopontin gene (spp 1). J Clin Invest 101:1468-1478, 1998
18. 18. HUGO C, PICHLER R, GORDON K, SCHMIDT R, AMIEVA M, COUSER WG, JOHNSON RJ: The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor, in experimental mesangial proliferative glomerulonephritis. J Clin Invest 97:2499-2508, 1998
19. 19. TAMAKI K,OKUDA S, ANDO T, IWAMOTO T, NAKAYAMA M, FUJISHIMA M: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 45:525-536, 1994
20. 20. DANIELPOUR D, DART LL, FLANDERS KC, ROBERTS AB, SPORN MB: Immunodetection and quantitation of the two forms of transforming growth factor beta (TGF-β1 and TGF-β2) secreted by cells in culture. J Cell Physiol 138:79-86, 1989
21. 21. O'BRIEN KD, GORDON D, DEER S, FERGUSON M, CHAIT A: Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atheroselerotic plaques. J Clin Invest 89:1544-1550, 1992
22. 22. BAKER AJ, MOONEY A, HUGHES J, LOMBARDI D, JOHNSON RJ, SAVILL J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis, J Clin Invest 94:2105-2116, 1994
23. 23. DE LARCO JE, TODARO GJ: Epithelioid and fibroblastic rat kidney cell clones: Epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation. J Cell Physiol 94:2105-2116, 1989
24. 24. MALAYANKAR UM, ALMEIDA M. JOHNSON RJ, PICHLER RH, GIACHELLI CM: Osteopontin regulation in cultured rat renal epithelial cells. Kidney Int 51:1766-1773, 1997
25. 25. LlAW L, LOMBARDI DM, ALMEIDA MM, SCHWARTZ SM, DEBLOIS D, GIACHELLI CM: Neutralizing antibodies inhibit rat carotid neointimal thickening after endothelial denudation. Arteriosel Thromb Vasc Biol 17:188-193, 1997
26. 26. SCATENA M, ALMEIDA M, CHAISSON ML, FAUSTON N, NICOSIA RF, GIACHELLI CM: NFKB mediates avb3 integrin induced endothelial cell survival. J Cell Biol 141:1083-1093, 1998
27. 27. SAVILI JS, WYLLIE AW, HENSON JE, WALPORT MJ, HENSON PM, HASLETT C: Macrophage phagocytosis of aging neutrophils in inflammation: Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83:865-875, 1989
28. 28. HOYER JR, OTVOS L JR, URGE L: Osteopontin in urinary stone formation. Ann NY Acad Sci 760:257-265, 1995
29. 29. SINGH RP, PATARCA R, SCHWARTZ J, SINGH P, CANTOR H: Definition of a specific interaction between the early T lymphocyte activation (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 171:1931-1942, 1990
30. 30. LIAW L, SKINNER MP, RAINES EW, Ross R, CHERESH DA, SCHWARTZ SM, GIACHELLI CM: The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of α,β, in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 95:713-724, 1995
31. 31. WEBER GF, ASHKAR S, GLIMCHER ML, CANTOR H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509-512, 1996
32. 32. SHARMA AK, MAUER SM, KIM Y, MICHAEL A: Interstitial fibrosis in obstructive nephropathy. Kidney Int 44:744-788, 1993
33. 33. KANETO H, MORRISSEY J, KLAHR S: Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44:313-321, 1993
34. 34. KLAHR S, MORRISSEY J, ISHIDOYA S: Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis 26:141-146, 1995
35. 35. KANETO H, MORRISEY J, MCCRACKEN R. REYES A, KLAHR S: Osteopontin expression in the kidney during unilateral ureteral obstruction. Miner Electroyte Metab 24:227-237, 1998
36. 36. WOLF G, MEULLER E, STAHL RAK, ZIYADEH FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 92:1366-1372, 1993
37. 37. Yu XQ, NIKOLIC-PATERSON DJ, MU W, GIACHELLI CM, ATKINS RC, JOHNSON RJ, LAN HY: A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. Proc Assoc Am Phys 110:50-64, 1998
38. 38. MAIN IW, NIKOLIC-PETERSON DJ, ATKINS RC: T cells and macrophages and their roles in renal injury. Semin Nephrol 12:395-407, 1992
39. 39. BORDER WA, NOBLE NA, KETTELER M: TGF-beta: A cytokine mediator of glomerulosclerosis and a target for therapeutic intervention. Kidney Int 49(Suppl):S59-S61, 1995
40. 40. SUGIYAMA HN, KASHIHARA H, MAKINO H, YAMASAKI Y, OTA A: Apoptosis in glomerular sclerosis. Kidney Int 50:103-111, 1996
41. 41. THOMAS S, ANDERSON S, GORDON KL, OYAMA TT, SHANKLAND SJ, JOHNSON RJ: Tubulo-interstitial disease in aging: Evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol 9:231-242, 1998
42. 42. TRUONG LD, PETRUSEVKA G, YANG G, GURPINAR T, SHAPPELL S, LECHAGO J, ROUSE D, SUKI WN: Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int 50:200-207, 1996
43. 43. ROLLO ED, LASKIN DL, DENHARDT DT: Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J Leuk Biol 60:397-404, 1996
44. 44. ROLLO ED, DENHARDT DT: Differential effects osteopontin on the cytotoxic activity of macrophages from young and old mice. Immunology 88:642-647, 1996
45. 45. ROGERS SA, PADANILAM BJ, HRUSKA KA, GIACHELLI CM, HAMMERMAN MR: Metanephric osteopontin regulates nephrogenesis in vitro. Am J Physiol 272(Renal Physiol 41):F469-F476, 1997